Author: Tom Wilemon

Shown at Monday’s VICC Annual Scientific Retreat are (front row, from left) Timothy Blackwell, MD, Fabien Maldonado, MD, Denise Aberle, MD, Melinda Aldrich, PhD, MPH, Kim Sandler, MD, (back row, from left) Eric Grogan, MD, MPH, Sudhir Srivastava, PhD, MPH, M. Patricia Rivera, MD, Julien Sage, PhD, David Carbone, MD, PhD, and Scott Hiebert, PhD.

VICC Scientific Retreat focuses on lung cancer

May. 5, 2022—by Tom Wilemon Speakers at the Vanderbilt-Ingram Cancer Center (VICC) 23rd Annual Scientific Retreat celebrated “Advances in Lung Cancer Research” but noted that too many people with the disease are not benefiting from those achievements. “Lung cancer is our leading cause of cancer mortality. Twenty-nine percent of our total cancers are lung cancer. That’s the...

Study casts doubt on impact of menthol-flavored tobacco ban

Apr. 21, 2022—Vanderbilt research finds that a ban on the sale of menthol-flavored cigarettes that the U.S. Food and Drug Administration (FDA) is on track to implement may have unintended consequences.

Biltibo receives career development award to support hematology research

Apr. 21, 2022—Vanderbilt's Eden Biltibo, MD, a clinical fellow in the Division of Hematology and Oncology, has been selected for the 2022 ASH-CIBMTR-ASTCT Career Development Award.

Black patients with cancer face worse COVID outcomes: study

Mar. 31, 2022—Vanderbilt researchers have found that Black patients with cancer experienced significantly worse outcomes after COVID-19 diagnosis than non-Hispanic white cancer patients.

Berlin named interim leader of Hematology and Oncology

Mar. 24, 2022—Jordan Berlin, MD, has been appointed interim leader of Vanderbilt's Division of Hematology and Oncology in the Department of Medicine.

VUMC’s Pietenpol, Shyr named AACR Fellows

Mar. 22, 2022—Vanderbilt's Jennifer Pietenpol, PhD, and Yu Shyr, PhD, have been inducted as fellows of the American Association for Cancer Research Academy.

P. Brent Ferrell, MD, is part of a multidisciplinary team studying new approaches to understand and treat cancer.

Ferrell lands Mark Foundation for Cancer Research award

Mar. 17, 2022—Vanderbilt's Brent Ferrell, MD, is one of the recipients a 2022 Endeavor Award from the The Mark Foundation for Cancer Research.

As an 11-year cancer survivor, Lori Martin, BSN, MBA, RT(R), knows firsthand the importance of colorectal cancer screening.

Martin shares colorectal cancer story, urges early detection

Mar. 9, 2022—Vanderbilt Wilson County Hospital's Lori Martin uses her own experiences to educate patients about the importance of early detection of colorectal cancer.

Study finds World Trade Center responders at higher risk for blood cancer-associated mutations

Mar. 7, 2022—A study by Vanderbilt and New York City researchers found that 9/11 first responders to the World Trade Center have increased levels of mutations that escalate their risk for blood cancers or cardiovascular disease

Grant to support Haake’s research on kidney cancer

Feb. 17, 2022—Kure It Cancer Research has awarded a $200,000 grant to support kidney cancer research by Vanderbilt's Scott Haake, MD.

Travis Osterman, DO, MS, is working to establish common data standards for oncology clinicians and researchers.

Osterman plays key role in major oncology EHR initiative

Feb. 3, 2022—Vanderbilt's Travis Osterman, DO, MS, is leading an integral component of the Minimal Common Data Elements (mCODE) initiative, establishing common data standards for oncology clinicians and researchers.

New fund supports appendiceal cancer research

Jan. 27, 2022— by Tom Wilemon The newly established Dalton Family Foundation Appendix Cancer Research Fund will support investigations by the Division of Epidemiology at Vanderbilt University Medical Center to better understand this rare malignancy. An initial grant from the Dalton Family Foundation will fund the work of Andreana Holowatyj, PhD, MSCI, assistant professor of Medicine, and...